KNBIF (Kane Biotech) Repurchase of Stock: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Kane Biotech Repurchase of Stock?

Kane Biotech KNBIF -17.51% Repurchase of Stock is $0.00 Mil as of Jun. 2026. The stock has 5 warning signs investors should review.

Kane Biotech's Repurchase of Stock for the three months ended in Jun. 2026 was $0.00 Mil.

Kane Biotech's Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil.

Kane Biotech Repurchase of Stock Related Terms

Kane Biotech Repurchase of Stock Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Repurchase of Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Repurchase of Stock Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Repurchase of Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kane Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Mar26 Jun26
Repurchase of Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Kane Biotech Repurchase of Stock Calculation

A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of Stock represents the cash outflow to reacquire common stock during the period.

Repurchase of Stock for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Repurchase of Stock →
What does a Repurchase of Stock of $0.00 Mil mean?
Kane Biotech (KNBIF) has a Repurchase of Stock of $0.00 Mil as of Jun. 2026. Repurchase of Stock is the total amount of company share repurchases. View historical data for Kane Biotech and its competitors.
Is Kane Biotech's Repurchase of Stock too high?
Kane Biotech's current Repurchase of Stock is $0.00 Mil.
How does Kane Biotech's Repurchase of Stock compare to VRTX and REGN?
Kane Biotech's Repurchase of Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Repurchase of Stock for a Biotechnology company?
A good Repurchase of Stock depends on the Biotechnology industry context. However, Repurchase of Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Repurchase of Stock mean?
A high Repurchase of Stock can signal that a stock is expensive relative to its fundamentals. Repurchase of Stock is the total amount of company share repurchases. View historical data for Kane Biotech and its competitors. Kane Biotech's current Repurchase of Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Based on GuruFocus' analysis, Kane Biotech (KNBIF) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.02, compared to a current price of $0.02 — trading 10.5% below its estimated fair value. The current Repurchase of Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Repurchase of Stock calculated?
Repurchase of Stock is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Repurchase of Stock is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.